Home Eye Disorders

Eye Disorders

Latest
Eye Disorders

Clearside Scraps Xipere for RVO after Phase III Failure; Shares Tumble...

Eye Disorders

Ophthotech Expands Eye Disease Pipelines of Small Molecule, Gene Therapy Candidates

Source: Pixabay
Eye Disorders

Parkinson’s Diagnosis Could Be in the Eyes of the Holder

Eye Disorders

Could Glaucoma Be an Autoimmune Disease?

Astellas Pharma sees potential in Quethera's gene therapy program
Eye Disorders

Astellas Expands Its Eye Disorder Pipeline with Quethera Purchase

Source: Retinitis pigmentosa by Christian Hamel [CC BY-SA 3.0]
Eye Disorders

Increasing Eye Cells’ Ability to Process Misfolded Proteins May Prevent Retinal...

A view of the eye of a dog affected by the canine equivalent of Best disease before (left) and five years after (right) the gene therapy underscores how the treatment reversed a sizeable lesion—and lasted. The black mark visible on the treated eye is the injection site. [University of Pennsylvania]
Eye Disorders

Gene-Therapy Trials for Inherited Form of Blindness Could Start in Two...

Eye Disorders

EyeGate Pharma Eye Treatment EGP-437 Fails Phase IIb Trial

Eye Disorders

Allergan Eliminating 1400 Jobs as Dry-Eye Drug Faces Generic Competition

Eye Disorders

Development of Eye Disease Combination Therapy Halted by Regeneron, Bayer after...

Load more

Recently Featured

Stay Connected

557,677FansLike
45,823FollowersFollow
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up